These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 28292316)
1. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm. Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316 [TBL] [Abstract][Full Text] [Related]
2. Re-emergence of Babesia conradae and effective treatment of infected dogs with atovaquone and azithromycin. Di Cicco MF; Downey ME; Beeler E; Marr H; Cyrog P; Kidd L; Diniz PP; Cohn LA; Birkenheuer AJ Vet Parasitol; 2012 Jun; 187(1-2):23-7. PubMed ID: 22305297 [TBL] [Abstract][Full Text] [Related]
3. Babesia negevi infection in dogs and response to treatment. Salant H; Nachum-Biala Y; Zivotofsky D; Tzur TE; Baneth G Ticks Tick Borne Dis; 2024 Jan; 15(1):102282. PubMed ID: 37989015 [TBL] [Abstract][Full Text] [Related]
4. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy against babesiosis. Vial HJ; Gorenflot A Vet Parasitol; 2006 May; 138(1-2):147-60. PubMed ID: 16504402 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs. Kirk SK; Levy JK; Crawford PC J Vet Intern Med; 2017 Jul; 31(4):1108-1112. PubMed ID: 28625019 [TBL] [Abstract][Full Text] [Related]
7. Repeated imidocarb treatment failure suggesting emerging resistance of Babesia canis in a new endemic area in north-eastern Germany. Weingart C; Krücken J; Kohn B Ticks Tick Borne Dis; 2024 May; 15(3):102315. PubMed ID: 38301344 [TBL] [Abstract][Full Text] [Related]
8. Antiprotozoal treatment of canine babesiosis. Baneth G Vet Parasitol; 2018 Apr; 254():58-63. PubMed ID: 29657012 [TBL] [Abstract][Full Text] [Related]
9. Atovaquone and azithromycin for the treatment of babesiosis. Krause PJ; Lepore T; Sikand VK; Gadbaw J; Burke G; Telford SR; Brassard P; Pearl D; Azlanzadeh J; Christianson D; McGrath D; Spielman A N Engl J Med; 2000 Nov; 343(20):1454-8. PubMed ID: 11078770 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of atovaquone and azithromycin or imidocarb dipropionate in cats with acute cytauxzoonosis. Cohn LA; Birkenheuer AJ; Brunker JD; Ratcliff ER; Craig AW J Vet Intern Med; 2011; 25(1):55-60. PubMed ID: 21143646 [TBL] [Abstract][Full Text] [Related]
11. Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus. Gray JS; Pudney M J Parasitol; 1999 Aug; 85(4):723-8. PubMed ID: 10461956 [TBL] [Abstract][Full Text] [Related]
12. Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts. Tuvshintulga B; Sivakumar T; Nugraha AB; Ahedor B; Batmagnai E; Otgonsuren D; Liu M; Xuan X; Igarashi I; Yokoyama N J Infect Dis; 2022 Jan; 225(2):238-242. PubMed ID: 34664651 [TBL] [Abstract][Full Text] [Related]
13. In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys. Kumar S; Gupta AK; Pal Y; Dwivedi SK J Vet Med Sci; 2003 Nov; 65(11):1171-7. PubMed ID: 14665744 [TBL] [Abstract][Full Text] [Related]
14. Failure of imidocarb dipropionate to eliminate Hepatozoon canis in naturally infected dogs based on parasitological and molecular evaluation methods. Sasanelli M; Paradies P; Greco B; Eyal O; Zaza V; Baneth G Vet Parasitol; 2010 Aug; 171(3-4):194-9. PubMed ID: 20444549 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. Birkenheuer AJ; Levy MG; Breitschwerdt EB J Vet Intern Med; 2004; 18(4):494-8. PubMed ID: 15320586 [TBL] [Abstract][Full Text] [Related]
16. Microscopic and molecular analysis of Babesia canis in archived and diagnostic specimens reveal the impact of anti-parasitic treatment and postmortem changes on pathogen detection. Huber D; Beck A; Anzulović Ž; Jurković D; Polkinghorne A; Baneth G; Beck R Parasit Vectors; 2017 Oct; 10(1):495. PubMed ID: 29047398 [TBL] [Abstract][Full Text] [Related]
17. Molecular characterisation of Babesia gibsoni infection from a pit-bull terrier pup recently imported into South Africa. Matjila PT; Penzhorn BL; Leisewitz AL; Bhoora R; Barker R J S Afr Vet Assoc; 2007 Mar; 78(1):2-5. PubMed ID: 17665757 [TBL] [Abstract][Full Text] [Related]
18. Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin. Sakuma M; Setoguchi A; Endo Y J Vet Intern Med; 2009; 23(3):493-8. PubMed ID: 19645835 [TBL] [Abstract][Full Text] [Related]
19. Atovaquone in the treatment of Babesia microti infections in hamsters. Wittner M; Lederman J; Tanowitz HB; Rosenbaum GS; Weiss LM Am J Trop Med Hyg; 1996 Aug; 55(2):219-22. PubMed ID: 8780464 [TBL] [Abstract][Full Text] [Related]
20. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate. Brandão LP; Hagiwara MK; Myiashiro SI Vet Parasitol; 2003 Jun; 114(4):253-65. PubMed ID: 12809752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]